| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/10/1993 | US5234956 Reducing increase in calcium ion concenration; administering nitroglycerin, nitroprusside or derivatives thereof; treating AIDS, Alzheimer's, CNS disorders, cardiovascular disorders |
| 08/10/1993 | US5234912 Pharmaceutical compositions comprising recombinant BPI proteins and a lipid carrier and uses thereof |
| 08/10/1993 | US5234911 Antiinflammatory agents |
| 08/10/1993 | US5234910 Acid inhibitor of bacterial origin |
| 08/10/1993 | US5234909 Dipeptidic amides derived from glycyl-serine as surfactants or hydrating agents and cosmetic, pharmaceutical or alimentary compositions containing the same |
| 08/10/1993 | US5234908 Method of treating gastrointestinal ulcers with platelet derived growth factor |
| 08/10/1993 | US5234907 Bronchodilator agent |
| 08/10/1993 | US5234906 Hyperglycemic compositions |
| 08/10/1993 | US5234904 For food and drinks |
| 08/10/1993 | US5234903 A deoxygenated, reduced hemoglobin conjugated to a polyoxyalkylene glycol; synthetic blood; oxygen transport; extended half-life; nontoxic |
| 08/10/1993 | US5234822 Diagnosis, therapy, vaccines |
| 08/10/1993 | US5234686 Treatment of thrombotic disorders |
| 08/10/1993 | US5234685 Method of determining incompatibility-reaction-causing substances in blood products as well as a method of inactivating said incompatibility-reaction-causing substances |
| 08/10/1993 | US5234684 Method for the prevention and treatment of bovine mastitis |
| 08/10/1993 | CA1321282C Parathyroid hormone antagonists |
| 08/10/1993 | CA1321281C Humoral hypercalcemic factor antagonists |
| 08/10/1993 | CA1321143C High titer varicella zoster immune globulin for intravenous administration |
| 08/10/1993 | CA1321140C Use of mullerian inhibiting substance as a contraceptive agent |
| 08/10/1993 | CA1321139C Agent for the therapy of factor viii-resistant hemophilia a, and a process for the preparation thereof |
| 08/10/1993 | CA1321138C One-component tissue adhesive and a process for the production thereof |
| 08/07/1993 | WO1993015754A1 Hepatic growth factor receptor |
| 08/07/1993 | CA2129423A1 Hepatic growth factor receptor |
| 08/06/1993 | CA2087781A1 Method of treating presenile or senile dementia |
| 08/05/1993 | WO1993015405A1 Carcinoma associated antigen (sk1) monoclonal antibodies against sk1, methods of producing these antibodies and use therfor |
| 08/05/1993 | WO1993015234A1 Activated factor xiii |
| 08/05/1993 | WO1993015211A1 New polypeptides having granulocyte colony stimulating activity, preparation thereof and pharmaceutical compositions containing said polypeptides |
| 08/05/1993 | WO1993015210A1 Monomeric and dimeric antibody-fragment fusion proteins |
| 08/05/1993 | WO1993015204A1 Serum-human albumin, preparation and utilization |
| 08/05/1993 | WO1993015203A2 Polypeptides with fibronectin binding sites as modulators for matrix assembly |
| 08/05/1993 | WO1993015202A1 Aamp-1, a protein with local homologies to hiv-1 env and nef proteins |
| 08/05/1993 | WO1993015201A1 Novel protein tyrosine kinases |
| 08/05/1993 | WO1993015200A1 Antithrombotic polypeptides as antagonists of the binding of vwf to platelets or to subendothelium |
| 08/05/1993 | WO1993015199A1 Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides |
| 08/05/1993 | WO1993015198A1 Polypeptides derived from human aiv apolipoprotein, preparation and use thereof |
| 08/05/1993 | WO1993015197A2 Expression of osteogenic factor op-1 in cells of spodoptera frugiperda infected with recombinant baculovirus |
| 08/05/1993 | WO1993015195A1 Granulins from leukocytes |
| 08/05/1993 | WO1993015194A1 Enhancement of ribozyme catalytic activity by a neighboring facilitator oligonucleotide |
| 08/05/1993 | WO1993015193A1 Mammalian expression systems for hcv proteins |
| 08/05/1993 | WO1993015187A1 Nucleozymes |
| 08/05/1993 | WO1993015184A1 Assay for neuro-excitatory agents |
| 08/05/1993 | WO1993015113A1 An immunotoxin including a cytotoxin with an unpaired cysteine residue in or near its receptor-binding site |
| 08/05/1993 | WO1993015112A2 COMPOUNDS AND METHODS FOR INHIBITING β-PROTEIN FUNCTION |
| 08/05/1993 | WO1993015109A2 Parathyroid hormone fragments, their preparation and medicaments containing the same |
| 08/05/1993 | WO1993015107A1 Amino procollagen 1(i) peptides |
| 08/05/1993 | WO1993015106A1 Cyclic calcitonine derivatives and method for their production |
| 08/05/1993 | WO1993015105A1 Process for recovering a high-purity virus-inactivated factor viii by anion exchanger chromatography |
| 08/05/1993 | WO1993015078A1 Carbapenems containing a carboxy substituted phenyl group, processes for their preparation, intermediates and use as antibiotics |
| 08/05/1993 | WO1993015062A1 Opioid diarylmethylpiperazines and piperidines |
| 08/05/1993 | WO1993015059A1 3-phenylureido-azepin-2-ones and -benzazepin-2-ones useful as cholecystokinin antagonists |
| 08/05/1993 | WO1993014796A1 Peritoneal dialysis composition and method usable during and after peritonitis |
| 08/05/1993 | WO1993014783A1 Growth factor compositions, preparation and use |
| 08/05/1993 | WO1993014782A1 Methods of controlling the proliferation of macrophages |
| 08/05/1993 | WO1993014781A1 Novel peptides and method for altering the activity of allosteric proteins |
| 08/05/1993 | WO1993014780A1 The use of a compound for the manufacture of a medicament for the treatment of hiv infection |
| 08/05/1993 | WO1993014779A1 Trypsin inhibitors |
| 08/05/1993 | WO1993014778A1 Ex vivo gene transfer |
| 08/05/1993 | WO1993014777A1 PEPTIDYL DERIVATIVES AS INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 08/05/1993 | WO1993014776A1 Icam-related protein |
| 08/05/1993 | WO1993014754A1 Histamine derivatives and methods for their use as immunomodulators |
| 08/05/1993 | WO1993014750A2 Amino acids useful as inhibitors of the advanced glycosylation of proteins |
| 08/05/1993 | WO1993014640A1 Antibacterial agent and treatment of article therewith |
| 08/05/1993 | WO1993013204A3 Agent for stimulating animal cell division |
| 08/05/1993 | WO1993012781A3 Creatine analogs having antiviral activity |
| 08/05/1993 | WO1993009234A3 Suppressor and progenitor cells |
| 08/05/1993 | WO1993009233A3 Recombinant amyloid precursor protein inhibitor domain and treatment of various disease states |
| 08/05/1993 | WO1993006866A3 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction |
| 08/05/1993 | DE4203040A1 Neue parathormonfragmente, deren herstellung und diese enthaltende arzneimittel New parathyroid hormone fragment, containing their production and this drug |
| 08/05/1993 | CA2626680A1 Peritoneal dialysis composition and method usable during and after peritonitis |
| 08/05/1993 | CA2129119A1 Nucleozymes |
| 08/05/1993 | CA2129115A1 Polypeptides with fibronectin binding sites as modulators for matrix assembly |
| 08/05/1993 | CA2129019A1 Growth factor compositions, preparation and use |
| 08/05/1993 | CA2128879A1 Aamp-1, a protein with local homologies to hiv-1 env and nef proteins |
| 08/05/1993 | CA2128877A1 Amino procollagen 1(1) peptides |
| 08/05/1993 | CA2128790A1 Use of a compound for the manufacture of a medicament for the treatment of hiv infection |
| 08/05/1993 | CA2128722A1 Novel protein tyrosine kinases |
| 08/05/1993 | CA2128700A1 Carcinoma associated antigen (sk1) and monoclonal antibodies against sk1, methods of producing these antibodies and use therefor |
| 08/05/1993 | CA2128616A1 Ex vivo gene transfer |
| 08/05/1993 | CA2128516A1 Histamine derivatives and methods for their use as immunomodulators |
| 08/05/1993 | CA2128032A1 Activated factor xiii |
| 08/05/1993 | CA2126974A1 New parathormone fragments, their preparation and medicaments containing these |
| 08/05/1993 | CA2126092A1 Antithrombotic polypeptides as antagonists of the binding of vwf to platelets or to subendothelium |
| 08/05/1993 | CA2125979A1 New polypeptides with a stimulating activity for granulocytes colonies; process for preparing the same and pharmaceutical compositions containing them |
| 08/05/1993 | CA2125877A1 Polypeptides derived from human aiv apolipoprotein, preparation and use thereof |
| 08/05/1993 | CA2117428A1 Enhancement of ribozyme catalytic activity by a neighboring facilitator oligonucleotide |
| 08/05/1993 | CA2117367A1 3-phenylureido-azepin-2-ones and benzazepin-2-ones useful as cholecystokinin antagonists |
| 08/04/1993 | WO1993014748A1 Remedy for dermatopathy and metallothionein inducer |
| 08/04/1993 | EP0553884A1 Purified tetrahydropyrimidine derivatives and pharmaceutical compositions comprising them |
| 08/04/1993 | EP0553667A1 Soluble LDL receptor, its production and use |
| 08/04/1993 | EP0553428A2 DNA 5' to an untranslated region upstream of a gene encoding a growth hormone receptor. Use as a sex promoter |
| 08/04/1993 | EP0553357A1 Novel prolyl endopeptidase inhibitors sna-115 and sna-115t, production thereof, and strain which produces said inhibitors |
| 08/04/1993 | EP0553312A1 Synthetic calcitonin peptides |
| 08/04/1993 | EP0553294A1 Methods and compositions for the treatment of cell proliferation disorders |
| 08/04/1993 | EP0553291A1 Treatment of autoimmune diseases by oral administration of autoantigens |
| 08/04/1993 | EP0553281A1 Preparation and characterization of liposomal formulations of tumor necrosis factor. |
| 08/04/1993 | EP0553272A1 Synthetic lung surfactant |
| 08/04/1993 | EP0553260A1 Substantially pure interleukin-9 receptor and uses thereof |
| 08/04/1993 | EP0553198A1 Regulation of immunoglobulin production by interleukin-9 |
| 08/04/1993 | EP0553133A1 Analogues of cyclolinopeptide a and the use thereof |
| 08/04/1993 | EP0553117A1 Genetically engineered coccidiosis vaccine |
| 08/04/1993 | EP0553113A1 Adhesion receptors for pathogenic or opportunistic microorganisms |